Researchers at the National Food and Agriculture Organization of Japan have made a significant breakthrough in the study of African swine fever (ASF) by developing a unique cell line of macrophages obtained from the blood of a tufted pig, a natural carrier of the ASFV virus. The RZJ/IBM cell line showed weaker viral replication than the previous IPKM cell line, enabling researchers to identify mechanisms that provide natural protection of African pigs against ASF. The findings could be the basis for innovative disease control approaches and the development of a vaccine to protect the global pig industry from economic losses.